Phaseline

Companies › Lee's Pharmaceutical

Lee's Pharmaceutical: clinical trials, targets and expected readouts

4 active drug programs in 20 registered trials: 7 Phase 3, 7 Phase 1, 5 Phase 4, 1 Phase 2; Oncology, Cardiovascular, Gastroenterology, Other; next expected readout Sep 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Socazolimab
IL-17A inhibitor
–Phase 3Cervical CancerSep 2027
5-Aminolevulinic Acid Hydrochloride Powder for Oral Solution
5-ALA is a prodrug that accumulates protoporphyrin IX in tumor cells; fluorescence is used
PPOXPhase 35-aminolevulinic AcidDec 2027
AU409–Phase 1Advanced Hepatocellular Carcinoma–
Fentanyl
Mu opioid receptor agonist
OPRM1Phase 1Cancer; Vaginal Delivery; Spinal Anesthesia Duration; Effect of Drug …–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06823349FentanylPhase 4Vaginal DeliveryOtherJun 2025
NCT07078201FentanylPhase 4Spinal Anesthesia DurationOtherJul 2025
NCT06479655FentanylPhase 4Effect of DrugOtherNov 2025
NCT06917898FentanylPhase 1Healthy Female VolunteerOtherApr 2026
NCT06953453FentanylPhase 1CancerOncologyJul 2026
NCT06374485AU409Phase 1Advanced Hepatocellular CarcinomaOncologyAug 2026
NCT07911943FentanylPhase 1Intra and Post Operative Pain ManagementOtherNov 2026
NCT07165262FentanylPhase 3EpilepsyOncologyMar 2027
NCT07443254FentanylPhase 1AnesthesiaOtherApr 2027
NCT06281951FentanylPhase 1AnalgesiaOtherJun 2027
NCT06281951FentanylPhase 1AnalgesiaOtherJun 2027
NCT07120763FentanylPhase 3Distal Radius Fracture ReductionOtherAug 2027
NCT04011150FentanylPhase 3Labor PainOtherAug 2027
NCT06459687SocazolimabPhase 3Cervical CancerOncologySep 2027
NCT07840183FentanylPhase 4Ventral HerniaGastroenterologySep 2027
NCT061604925-Aminolevulinic Acid Hydrochloride Powder for Oral SolutionPhase 35-aminolevulinic AcidOncologyDec 2027
NCT02278601FentanylPhase 3Breakthrough PainOtherDec 2027
NCT03167905FentanylPhase 2Depression, PostpartumPsychiatryDec 2027
NCT06464146FentanylPhase 3Limb InjuryOtherFeb 2028
NCT07556523FentanylPhase 4Transcatheter Aortic Valve Replacement (TAVR)CardiovascularApr 2028

Targets

OPRM1 (1) PPOX (1)

Companies with the same targets

Inventage Lab. Sun Pharmaceutical Industries Trevi Therapeutics Shionogi Currax Pharmaceuticals AgelessRx ReacX Pharmaceuticals Akyso Therapeutics Boulder Care Adneuris Therapeutics

Companies built like this

InxMed (Shanghai) Clarity Pharmaceuticals TYK Medicines Impact Therapeutics TransThera Sciences (Nanjing)

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.